当前位置: X-MOL 学术J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Results of IMPACT 2, a randomized study evaluating molecular profiling and targeted agents in metastatic cancer at MD Anderson Cancer Center.
Journal of Clinical Oncology ( IF 42.1 ) Pub Date : 2024-05-29 , DOI: 10.1200/jco.2024.42.16_suppl.3153
Apostolia Maria Tsimberidou 1 , Siqing Fu 2 , David S. Hong 2 , Sarina A. Piha-Paul 2 , Aung Naing 1 , Jordi Rodon Ahnert 1 , Timothy A. Yap 2 , Daniel D. Karp 2 , Ecaterina Elena Dumbrava 2 , John Heymach 1 , Jaffer A. Ajani 3 , Carrie Cartwright 1 , Jennifer Beck 4 , Clark R. Andersen 1 , Michael Kahle 1 , David J. Vining 5 , Jeffrey S. Ross 6 , Calvin Y. Chao 7 , Donald A. Berry 8 , Funda Meric-Bernstam 2
Affiliation  

Journal of Clinical Oncology, Volume 42, Issue 16_suppl, Page 3153-3153, June 2024.


中文翻译:


IMPACT 2 是一项评估 MD 安德森癌症中心转移性癌症分子谱和靶向药物的随机研究的结果。



《临床肿瘤学杂志》,第 42 卷,第 16 期_suppl,第 3153-3153 页,2024 年 6 月。
更新日期:2024-05-30
down
wechat
bug